Shenglan Li

2.2k total citations
58 papers, 1.5k citations indexed

About

Shenglan Li is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Shenglan Li has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in Shenglan Li's work include Pluripotent Stem Cells Research (10 papers), Glioma Diagnosis and Treatment (9 papers) and CRISPR and Genetic Engineering (7 papers). Shenglan Li is often cited by papers focused on Pluripotent Stem Cells Research (10 papers), Glioma Diagnosis and Treatment (9 papers) and CRISPR and Genetic Engineering (7 papers). Shenglan Li collaborates with scholars based in China, United States and Macao. Shenglan Li's co-authors include Haipeng Xue, Dali Li, Ying Liu, Di Jia, Dan Yang, Peng Jiang, Ying Liu, Dong Kim, Ying Liu and Wenbin Deng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Shenglan Li

54 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shenglan Li 805 250 223 181 169 58 1.5k
Holger Jastrow 675 0.8× 119 0.5× 162 0.7× 131 0.7× 173 1.0× 46 1.4k
Wendy Lee 947 1.2× 127 0.5× 162 0.7× 136 0.8× 485 2.9× 56 2.6k
Haiwei Wang 539 0.7× 114 0.5× 204 0.9× 174 1.0× 128 0.8× 87 1.1k
Yiming Zhou 1.4k 1.7× 197 0.8× 450 2.0× 117 0.6× 425 2.5× 74 2.5k
Yue Yang 1.4k 1.8× 194 0.8× 267 1.2× 111 0.6× 316 1.9× 80 2.3k
Artur Cieślar‐Pobuda 658 0.8× 140 0.6× 229 1.0× 229 1.3× 213 1.3× 33 1.3k
Xiaofeng Zhao 750 0.9× 77 0.3× 317 1.4× 87 0.5× 208 1.2× 46 1.4k
Jianmin Zhang 559 0.7× 86 0.3× 242 1.1× 206 1.1× 92 0.5× 55 1.2k
Ning‐Yi Shao 2.1k 2.6× 195 0.8× 415 1.9× 169 0.9× 260 1.5× 53 2.8k
Juntang Lin 947 1.2× 126 0.5× 379 1.7× 88 0.5× 148 0.9× 130 1.9k

Countries citing papers authored by Shenglan Li

Since Specialization
Citations

This map shows the geographic impact of Shenglan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Li more than expected).

Fields of papers citing papers by Shenglan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Li. The network helps show where Shenglan Li may publish in the future.

Co-authorship network of co-authors of Shenglan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Li. A scholar is included among the top collaborators of Shenglan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Li. Shenglan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shenglan, Xin Yang, Can Wang, et al.. (2025). A novel compound, SYHA1813, inhibits malignant meningioma growth directly by boosting p53 pathway activation and impairing DNA repair. Frontiers in Oncology. 15. 1522249–1522249.
2.
Zhao, Sen, Shenglan Li, Jill A. Rosenfeld, et al.. (2025). The utility of ultra-deep RNA sequencing in Mendelian disorder diagnostics. The American Journal of Human Genetics. 112(11). 2578–2590.
3.
Zhao, Sen, Hongzheng Dai, Jill A. Rosenfeld, et al.. (2025). Clinical validation of RNA sequencing for Mendelian disorder diagnostics. The American Journal of Human Genetics. 112(4). 779–792. 7 indexed citations
4.
Li, Shenglan, Haipeng Xue, Xiaohui Chen, et al.. (2025). Macrophage Migration Inhibitory Factor Suppresses Natural Killer Cell Response and Promotes Hypoimmunogenic Stem Cell Engraftment Following Spinal Cord Injury. Biology. 14(7). 791–791. 1 indexed citations
5.
6.
7.
Zhang, Rong, Can Wang, Xiaohong Zheng, et al.. (2023). Warburg effect‐related risk scoring model to assess clinical significance and immunity characteristics of glioblastoma. Cancer Medicine. 12(21). 20639–20654. 10 indexed citations
8.
Li, Shenglan, et al.. (2023). Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma. SHILAP Revista de lepidopterología. 2(2). 114–130. 6 indexed citations
9.
Jiang, Jing, Ce Wang, Feng Chen, et al.. (2023). Dietary B vitamins and glioma: A case–control study based on Chinese population. Frontiers in Nutrition. 10. 1122540–1122540. 5 indexed citations
10.
Li, Song, Xia Wan, Yuqin Deng, et al.. (2023). Predicting prognosis of nasopharyngeal carcinoma based on deep learning: peritumoral region should be valued. Cancer Imaging. 23(1). 14–14. 10 indexed citations
11.
Li, Shenglan, Can Wang, Jinyi Chen, et al.. (2023). Signaling pathways in brain tumors and therapeutic interventions. Signal Transduction and Targeted Therapy. 8(1). 8–8. 53 indexed citations
12.
Zheng, Yiyan, Haipeng Xue, Shenglan Li, et al.. (2022). Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Promotes Forelimb Functional Recovery after Cervical Spinal Cord Injury. Cells. 11(17). 2765–2765. 13 indexed citations
13.
Chen, Jinyi, Zhuang Kang, Shenglan Li, et al.. (2022). Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes. Frontiers in Immunology. 13. 911260–911260. 3 indexed citations
14.
15.
Li, Shenglan, Jinyi Chen, Feng Chen, et al.. (2021). Liposomal honokiol promotes hair growth via activating Wnt3a/β-catenin signaling pathway and down regulating TGF-β1 in C57BL/6N mice. Biomedicine & Pharmacotherapy. 141. 111793–111793. 31 indexed citations
16.
Li, Shenglan, et al.. (2020). MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level.. PubMed Central. 12(8). 4749–4756. 9 indexed citations
17.
Chen, Chen, Peng Jiang, Haipeng Xue, et al.. (2020). Author Correction: Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells. Nature Communications. 11(1). 1070–1070. 3 indexed citations
18.
Stertz, Laura, Guangsheng Pei, Gabriel R. Fries, et al.. (2020). Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients. Neuropsychopharmacology. 46(3). 673–682. 23 indexed citations
19.
Li, Shenglan, Haipeng Xue, Jianbo Wu, et al.. (2015). Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System. Stem Cells and Development. 24(24). 2925–2942. 20 indexed citations
20.
Karaçay, Bahri, Shenglan Li, & Daniel J. Bonthius. (2008). Maturation‐Dependent Alcohol Resistance in the Developing Mouse: Cerebellar Neuronal Loss and Gene Expression During Alcohol‐Vulnerable and ‐Resistant Periods. Alcoholism Clinical and Experimental Research. 32(8). 1439–1450. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Holger Jastrow Breakdown of academic impact, for papers by Wendy Lee Breakdown of academic impact, for papers by Haiwei Wang Breakdown of academic impact, for papers by Yiming Zhou Breakdown of academic impact, for papers by Yue Yang Breakdown of academic impact, for papers by Artur Cieślar‐Pobuda Breakdown of academic impact, for papers by Xiaofeng Zhao Breakdown of academic impact, for papers by Jianmin Zhang Breakdown of academic impact, for papers by Ning‐Yi Shao Breakdown of academic impact, for papers by Juntang Lin
Rankless by CCL
2026